Showing 361 to 375 of 945 results
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).
Confidentiality - guidance for registrants
The standards against which we assess education and training programmes